The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 2—Advanced Microfluidic Nasal In Vitro Model for Drug Absorption Testing
Pharmaceutics · 09.10.2023 · 15 (10) · 2439
DOI: 10.3390/pharmaceutics15102439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 09.10.2023. Verfasst von Eugen Viktor Koch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microtechnology, TU Braunschweig, Alte Salzdahlumer Str. 203, 38124 Braunschweig, Germany. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Open Access Publication Funds of Technische Universität Braunschweig.
Abstract (Originalsprache)
The nasal mucosa, being accessible and highly vascularized, opens up new opportunities for the systemic administration of drugs. However, there are several protective functions like the mucociliary clearance, a physiological barrier which represents is a difficult obstacle for drug candidates to overcome. For this reason, effective testing procedures are required in the preclinical phase of pharmaceutical development. Based on a recently reported immortalized porcine nasal epithelial cell line, we developed a test platform based on a tissue-compatible microfluidic chip. In this study, a biomimetic glass chip, which was equipped with a controlled bidirectional airflow to induce a physiologically relevant wall shear stress on the epithelial cell layer, was microfabricated. By developing a membrane transfer technique, the epithelial cell layer could be pre-cultivated in a static holder prior to cultivation in a microfluidic environment. The dynamic cultivation within the chip showed a homogenous distribution of the mucus film on top of the cell layer and a significant increase in cilia formation compared to the static cultivation condition. In addition, the recording of the ciliary transport mechanism by microparticle image velocimetry was successful. Using FITC-dextran 4000 as an example, it was shown that this nasal mucosa on a chip is suitable for permeation studies. The obtained permeation coefficient was in the range of values determined by means of other established in vitro and in vivo models. This novel nasal mucosa on chip could, in future, be automated and used as a substitute for animal testing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Microtechnology, TU Braunschweig, Alte Salzdahlumer Str. 203, 38124 Braunschweig, Germany.
- Center of Pharmaceutical Engineering, Franz-Liszt Str. 35 a, 38106 Braunschweig, Germany.
- Institute of Pharmaceutical Technology and Biopharmaceutics, TU Braunschweig, Mendelssohnstr. 1, 38106 Braunschweig, Germany.
- InSCREENeX GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.
ORCID-Profile: Eugen Viktor Koch, Stephan Reichl, Andreas Dietzel
Förderung
- Bundesministerium für Bildung und Forschung
- Open Access Publication Funds of Technische Universität Braunschweig
Zitieren
APA
Koch, E. V., Bendas, S., Nehlsen, K., May, T., Reichl, S., & Dietzel, A. (2023). The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 2—Advanced Microfluidic Nasal In Vitro Model for Drug Absorption Testing. Pharmaceutics, 15(10), 2439. https://doi.org/10.3390/pharmaceutics15102439
Vancouver
Koch EV, Bendas S, Nehlsen K, May T, Reichl S, Dietzel A. The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 2—Advanced Microfluidic Nasal In Vitro Model for Drug Absorption Testing. Pharmaceutics. 2023;15(10):2439. doi:10.3390/pharmaceutics15102439
BibTeX
@article{Koch2023,
author = {Koch, Eugen Viktor and Bendas, Sebastian and Nehlsen, Kristina and May, Tobias and Reichl, Stephan and Dietzel, Andreas},
title = {The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 2—Advanced Microfluidic Nasal In Vitro Model for Drug Absorption Testing},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {10},
pages = {2439},
doi = {10.3390/pharmaceutics15102439}
}
EUVIMED